Loading...

Verici Dx plc

VRCDFPNK
Healthcare
Medical - Diagnostics & Research
$0.003
$0.00(0.00%)
U.S. Market is Open • 11:57

Verici Dx plc Fundamental Analysis

Verici Dx plc (VRCDF) shows weak financial fundamentals with a PE ratio of -0.10, profit margin of -3.91%, and ROE of -1.93%. The company generates $0.0B in annual revenue with weak year-over-year growth of 2.30%.

Key Strengths

Cash Position64.18%
PEG Ratio-0.00

Areas of Concern

ROE-1.93%
Operating Margin-3.99%
Current Ratio0.91
We analyze VRCDF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -442.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-442.8/100

We analyze VRCDF's fundamental strength across five key dimensions:

Efficiency Score

Weak

VRCDF struggles to generate sufficient returns from assets.

ROA > 10%
-1.65%

Valuation Score

Excellent

VRCDF trades at attractive valuation levels.

PE < 25
-0.10
PEG Ratio < 2
-0.00

Growth Score

Moderate

VRCDF shows steady but slowing expansion.

Revenue Growth > 5%
2.30%
EPS Growth > 10%
51.27%

Financial Health Score

Moderate

VRCDF shows balanced financial health with some risks.

Debt/Equity < 1
0.11
Current Ratio > 1
0.91

Profitability Score

Weak

VRCDF struggles to sustain strong margins.

ROE > 15%
-193.02%
Net Margin ≥ 15%
-3.91%
Positive Free Cash Flow
No

Key Financial Metrics

Is VRCDF Expensive or Cheap?

P/E Ratio

VRCDF trades at -0.10 times earnings. This suggests potential undervaluation.

-0.10

PEG Ratio

When adjusting for growth, VRCDF's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Verici Dx plc at 0.29 times its book value. This may indicate undervaluation.

0.29

EV/EBITDA

Enterprise value stands at -0.69 times EBITDA. This is generally considered low.

-0.69

How Well Does VRCDF Make Money?

Net Profit Margin

For every $100 in sales, Verici Dx plc keeps $-3.91 as profit after all expenses.

-3.91%

Operating Margin

Core operations generate -3.99 in profit for every $100 in revenue, before interest and taxes.

-3.99%

ROE

Management delivers $-1.93 in profit for every $100 of shareholder equity.

-1.93%

ROA

Verici Dx plc generates $-1.65 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.65%

Following the Money - Real Cash Generation

Operating Cash Flow

Verici Dx plc generates limited operating cash flow of $-38.01M, signaling weaker underlying cash strength.

$-38.01M

Free Cash Flow

Verici Dx plc generates weak or negative free cash flow of $-38.02M, restricting financial flexibility.

$-38.02M

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

VRCDF converts -1.34% of its market value into free cash.

-1.34%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.29

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.37

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.91

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.93

vs 25 benchmark

ROA

Return on assets percentage

-1.65

vs 25 benchmark

ROCE

Return on capital employed

-2.91

vs 25 benchmark

How VRCDF Stacks Against Its Sector Peers

MetricVRCDF ValueSector AveragePerformance
P/E Ratio-0.1028.71 Better (Cheaper)
ROE-193.02%690.00% Weak
Net Margin-390.84%-44718.00% (disorted) Weak
Debt/Equity0.110.36 Strong (Low Leverage)
Current Ratio0.914.54 Weak Liquidity
ROA-164.51%-16533.00% (disorted) Weak

VRCDF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Verici Dx plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

69.17%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-75.13%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ